SCHEMBL29803601

SCHEMBL29803601

C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 1/20 0.53
▸ NMT1 P30419 5/20 0.47
▸ NMT2 O60551 4/20 0.47
▸ DPP4 P27487 1/20 0.44
▸ DPP8 Q6V1X1 1/20 0.44
▸ DPP9 Q86TI2 1/20 0.44
▸ TLR2 O60603 1/20 0.43
▸ CPB2 Q96IY4 3/20 0.42
▸ BACE1 P56817 4/20 0.41
▸ CTSD P07339 2/20 0.41
▸ GNPAT O15228 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29803184 0.98 FOLH1 (0.54) FOLH1NMT1NMT2DPP4DPP8
SCHEMBL29777786 0.98 FOLH1 (0.54) FOLH1NMT1NMT2DPP4DPP8
SCHEMBL29777842 0.98 FOLH1 (0.54) FOLH1NMT1NMT2DPP4DPP8
SCHEMBL29727679 0.95 FOLH1 (0.50) FOLH1NMT1NMT2DPP4DPP8
SCHEMBL29387782 0.94 FOLH1 (0.59) FOLH1DPP4DPP8DPP9CPB2
SCHEMBL29450599 0.94 FOLH1 (0.59) FOLH1DPP4DPP8DPP9CPB2
SCHEMBL29883499 0.94 FOLH1 (0.59) FOLH1DPP4DPP8DPP9CPB2
SCHEMBL29462542 0.94 FOLH1 (0.59) FOLH1DPP4DPP8DPP9CPB2
SCHEMBL8366769 0.93 FOLH1 (0.59) FOLH1DPP4DPP8DPP9CPB2
SCHEMBL31682383 0.93 FOLH1 (0.59) FOLH1DPP4DPP8DPP9CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114805489-A Polypeptide for repairing skin injury or mucous membrane injury and application thereof 四川好医生攀西药业有限责任公司 2022-07-29 — — CN claimed
CN-114805489-A Polypeptide for repairing skin injury or mucous membrane injury and application thereof 四川好医生攀西药业有限责任公司 2022-07-29 — — CN disclosed
Send feedback